Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone Diseases, Endocrine”

1,275 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,275 results

Post-approval studies (Phase 4)Study completedNCT00134745
What this trial is testing

Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome

Who this might be right for
Turner Syndrome
Line Cleemann 43
Not applicableLooking for participantsNCT06752577
What this trial is testing

Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney DiseasesKidney Transplant
Mayo Clinic 75
Not applicableStudy completedNCT04637360
What this trial is testing

Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment

Who this might be right for
Hyperparathyroidism; Secondary, Renal
Min-Sheng General Hospital 40
Not applicableActive Not RecruitingNCT03440697
What this trial is testing

Pathogenetic Basis of Aortopathy and Aortic Valve Disease

Who this might be right for
AortopathiesThoracic Aortic AneurysmAortic Valve Disease+19 more
Yale University 3,000
Large-scale testing (Phase 3)Study completedNCT01495468
What this trial is testing

Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children

Who this might be right for
Growth Hormone Deficiency
Changchun GeneScience Pharmaceutical Co., Ltd. 343
Testing effectiveness (Phase 2)Study completedNCT03789656
What this trial is testing

Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge)

Who this might be right for
Acromegaly
Crinetics Pharmaceuticals Inc. 47
Post-approval studies (Phase 4)UnknownNCT02668172
What this trial is testing

Pasireotide LAR and Pegvisomant Study in Acromegaly

Who this might be right for
Acromegaly
Erasmus Medical Center 60
Not applicableLooking for participantsNCT03455868
What this trial is testing

Bone Health After Bariatric Surgery in Patients With Type 2 Diabetes

Who this might be right for
Bariatric SurgeryBone HealthObesity, Morbid+1 more
CHU de Quebec-Universite Laval 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT06439758
What this trial is testing

Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes

Who this might be right for
Diabetes Type 2Osteoporosis
King Saud University 111
Testing effectiveness (Phase 2)Ended earlyNCT02719990
What this trial is testing

Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)

Who this might be right for
Adult Growth Hormone Deficiency (AGHD)
Versartis Inc. 36
Not applicableStudy completedNCT00459940
What this trial is testing

The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients

Who this might be right for
Growth Hormone Deficiency
University of Aarhus 20
Not applicableUnknownNCT05760118
What this trial is testing

Awareness of Osteoporosis in Diabetes Mellitus Patients

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+2 more
Uskudar State Hospital 400
Large-scale testing (Phase 3)Study completedNCT02354508
What this trial is testing

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 123
Testing effectiveness (Phase 2)Looking for participantsNCT06906874
What this trial is testing

Activated Charcoal Use in Chronic Kidney Disease Patients

Who this might be right for
End Stage Renal Disease (ESRD)CKD 5D, HemodialysisCKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder
Mansoura University 40
Post-approval studies (Phase 4)Study completedNCT00642720
What this trial is testing

Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic Patients

Who this might be right for
Quality of LifeAcromegaly
Erasmus Medical Center 20
Not applicableNot Yet RecruitingNCT06326853
What this trial is testing

Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models

Who this might be right for
Endocrine DisordersAdiposityPituitary Adenoma+3 more
IRCCS San Raffaele 200
Not applicableLooking for participantsNCT06805812
What this trial is testing

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

Who this might be right for
Breast AdenocarcinomaBreast Cancer Stage IVBreast Cancer, Metastatic+38 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 3,500
Testing effectiveness (Phase 2)UnknownNCT03221088
What this trial is testing

PEG-somatropin in the Treatment of Children With Idiopathic Short Stature

Who this might be right for
Dwarfism
Changchun GeneScience Pharmaceutical Co., Ltd. 360
Testing effectiveness (Phase 2)Ended earlyNCT05116046
What this trial is testing

Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondroplasia

Who this might be right for
Achondroplasia
Pfizer 35
Post-approval studies (Phase 4)Study completedNCT00145405
What this trial is testing

Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction

Who this might be right for
Acromegaly
Odense University Hospital 12
Load More Results